1. Invited essay {#sec1}
================

The world is presently grappling with a global pandemic known as coronavirus (i.e., COVID-19; [@bib77]). At the time of this writing, 18.6 million confirmed cases and over 700,000 deaths due to COVID-19 have been reported globally ([@bib206]). Although most individuals infected with COVID-19 present with minimal symptoms, 15--20% of those who contract the disease experience severe symptoms that require medical intervention and hospitalizations ([@bib77]; [@bib122]; [@bib159]; [@bib206]). Select segments of the population are at greater risk for more severe COVID-19 symptoms, including older persons and those with underlying medical conditions (e.g., heart disease, diabetes, liver disease, chronic lung disease, and being immunocompromised; [@bib97]; [@bib122]; [@bib197]; J. [@bib242]). At the present time there is no treatment or vaccine for COVID-19 and many parts of the world, including the United States (U.S.), continue to experience daily increases in cases and deaths.

The pandemic has affected the world in a deep and far reaching manner across nearly every level of analysis, ranging from personal (e.g., death, developing a COVID-19 illness, elevated poor mental health) to economic (e.g., economic recession, financial insecurity, bankruptcy) to social (e.g., isolation, inability to attend work or school, loss of developmental milestones such as graduation) ([@bib79]; [@bib239]; [@bib244]). The psychological and lifestyle adjustment needed to cope with COVID-19 has offered a significant obstacle for many families and individuals. For example, many caregivers have had to balance working at home with the additional responsibility of homeschooling their children. Additionally, the stress-related burden of COVID-19 has negatively impacted interpersonal relationships (e.g., conflict with a partner, domestic violence) due to close living circumstances, social restriction, and heightened worries. These pandemic-related issues sit in the larger context of the lack of information about the 'true' nature of COVID-19 (i.e., its etiology; [@bib77]) and misinformation across media and social outlets. COVID-19 has not affected all persons equally and many vulnerable subgroups are differentially exposed to risks. For example, racial/ethnic minority groups, individuals who are homeless, incarcerated or detained (e.g., immigration detention centers), or live-in poverty-stricken environments are particularly susceptible to COVID-19 related problems even when not directly infected ([@bib21]; [@bib183]; [@bib238]).

Governments around the world, including state and local constituents, are attempting to respond to the pandemic via various measures, ranging from the implementation of social distancing protocols, initiation of efforts to rapidly develop an efficacious COVID-19 vaccine, use of protective gear (e.g., face masks), public health messaging (e.g., how to wash hands properly to remove virus potential), restricting travel, closing borders, and shutting down major parts of the economy, among other tactics ([@bib81], p. 31; [@bib169]). Many governments have had to issue emergency declarations and offer some form of immediate financial assistance to businesses and families.

Many countries and some U.S. states are opening some aspect up their economies following relative success of social distancing. From countries to state and local municipalities, 'opening up' can involve different strategies (e.g., staggering the opening of businesses and schools) and mean different things (e.g., availability of medical supplies and COVID-19 testing capabilities, sanitation protocols), creating the potential for wide-spread confusion. During this time, there simultaneously remains a serious concern about the onslaught of future pandemic waves and the lack of an effective treatment for COVID-19. The uncontrollability and unpredictability related to COVID-19 and its health, social, and economic consequences is apt to elicit acute stress and continued worry about what the future may hold for individuals, families, communities, businesses, and countries (C. [@bib226]). In many respects, the COVID-19 pandemic serves as a broad-based stressor and may interact with diatheses represented at the individual, familial, community, and population level. Behavioral scientists play an integral role in the acute and longer-term management of negative psychological, addictive, and health behavior consequences associated with the COVID-19 pandemic. Indeed, behavioral scientists currently are and will continue to work with public health, medicine, and governmental bodies to manage the psychological, addictive behavior, and health behavior aftermath of COVID-19 for youth, adults, and older adults. These activities include direct assessment and clinical care as well as policy-level actions. Like the work of other allied disciplines (e.g., public health, medicine, social work), behavioral scientists help determine the short- and longer-term impact of COVID-19 and play an integral role in shaping how we -- as a global community -- respond to the most certain risk of future pandemics.

The aim of this invited article in *Behaviour Research and Therapy* is to offer a conceptual essay that discusses the psychological, addictive, and health behavior correlates/issues related to the COVID-19 pandemic from a behavioral science perspective. The limited empirical study of psychologically-based behavioral outcomes associated with COVID-19 lends to the current essay necessarily maintaining a commentary function, but with the clear objective of detailing the scientifically informed implications for mental health, addiction, and health behavior; many of which will have 'downstream' effects. We have organized the article around some of the most clinically important psychological disorders, addictive behaviors, and health behaviors for well-being.

In the first section, we describe the COVID-19 implications for mental health focusing on (a) anxiety/stress and mood disturbance, (b) obsessive compulsive symptoms and disorders, and (c) posttraumatic stress. Such mental health problems, although certainly not exhaustive of the scope of psychological disorders impacted by COVID-19, are some of the most common mental health issues in the general population and are frequently comorbid with chronic illness. In the second section, we focus on addictive behaviors, including (d) tobacco (combustible and electronic), (e) alcohol use and misuse, and (e) cannabis. These forms of drug use represent the most prevalent types of substance use and are frequently associated with chronic illness and premature death. In the third section, we spotlight health behavior and chronic illness by discussing the role of (f) sleep health and behavior, (g) chronic illness using the example of HIV/AIDS as an illustrative model, and (h) physical activity. Health behaviors represent vital targets for the mitigation of COVID-related disease and may play a key role in psychological adjustment and recovery. In the final section, we highlight sociocultural factors (e.g., race/ethnicity, economic adversity), developmental considerations, and the role of individual difference factors for psychological, addictive, and health behavior and chronic illness. We conclude by offering an integrative COVID-19 stress-based model that could be used to guide research focused on the stress-related burden of the pandemic.

2. Section one {#sec2}
==============

2.1. Anxiety, stress, and mood {#sec2.1}
------------------------------

Fear is an adaptive defense mechanism that is fundamental for survival and involves several psychological and biological processes of preparation for a response to potentially threatening events. COVID-19 represents a true threat, with many unknowns. If you are infected, there is a chance you could die, regardless of your current age, sex, or health status. As such, fear is a natural and adaptive response to this pandemic. On the other hand, every year tens of thousands die from influenza as well as many other preventable or unexpected causes. This raises the key question regarding the degree to which we should be anxious and fearful of COVID-19. How much anxiety is reasonable? Since even basic knowledge about COVID-19 is undeveloped, it will be difficult to clearly discriminate between normal, adaptive fear responses and less adaptive responses. That said, such an overarching true threat and the concomitant stressors such as social isolation, economic uncertainty and so forth could in fact recalibrate what is considered a normal level of anxiety in the general population. Research has demonstrated that trait levels of anxiety have increased in the US in recent decades, though the cause of such increases is unknown ([@bib216]). The COVID-19 pandemic is likely to contribute to these basic levels of trait anxiety, thus creating a "new normal" level of anxiety.

If we consider the likely general increase in anxiety and stress in the context of diathesis-stress conceptualizations of mental illness, we expect that such a salient and broad reaching stressor to increase the incidence of pathological anxiety. Anxiety conditions are already highly prevalent ([@bib12]), and we may see an increased incidence of anxiety psychopathology if the pandemic serves to push vulnerable individuals toward the expression of maladaptive levels of anxiety. Moreover, those with preexisting conditions are likely to have their symptoms intensify. One could further speculate that forms of pathological anxiety will increase. First responders and hospital personnel, particularly in affected areas are already showing troubling signs of stress and psychopathology ([@bib101]). It is highly likely that we will see increased rates of generalized anxiety and posttraumatic stress related to the pandemic and its sequelae.

Beyond the somewhat vague notion of COVID-19 acting as a stressor to increase both normal and pathological anxiety, it is interesting to consider the specific mechanisms that play a role in this process. There are several well-established parameters that relate to the genesis and maintenance of anxiety that seem highly relevant to the current situation. These processes include perceptions relating to predictability/certainty and controllability of threat ([@bib14]). Coming across a shark while swimming is quite different from viewing the same shark in an aquarium since a potential threat in the wild is far less predictable or controllable than one in an enclosure. Historically, epidemics and pandemics were considered divine punishments that were essentially uncontrollable. Although medical understanding of pathogens has advanced, globalization now facilitates the spread of pathological agents, which diminishes the degree to which we can control them. Similarly, naturally occurring mutations and adaptation of viruses ensure that novel pathogens like COVID-19 will emerge and spread. These conditions leave us in a state of uncertainty, except that we can be certain that COVID-19 and other infectious agents will persist. Thus, COVID-19 affects many of the core anxiety generating mechanisms since it leads to a sense of diminished predictability and controllability along with increased uncertainty relating to a true threat. Ultimately, the COVID-19 pandemic creates an ideal environment for the onset, maintenance, and exacerbation of anxiety symptoms and syndromes.

2.2. Trauma and posttraumatic stress {#sec2.2}
------------------------------------

The *DSM-5* posttraumatic stress disorder (PTSD) Criterion A ([@bib6], p.271) defines trauma as "exposure to actual or threatened death." Individuals who are closer to that exposure \-- providing healthcare to those infected, witnessing the deleterious and perhaps deadly effects of the virus on patients or loved ones, enduring losses of patients, family, or friends \-- might experience the crisis as potentially traumatic. People on the frontlines of the pandemic, including healthcare personnel, first responders, grocery store clerks, and other essential workers, encounter the threat of possible exposure to the virus regularly and on an ongoing basis. Similarly, incarcerated populations and those who might feel compelled, financially or otherwise, to work in close quarters without adequate personal protective equipment (e.g., factory workers) may be exposed to the COVID-19 virus for extended periods without perceived or actual recourse and suffer negative mental health repercussions as a result. COVID-19 survivors, particularly those who might have struggled through various medical procedures and prolonged hospitalizations, may emerge with unique or shared constellations of mental health reactions from risk to resilience. Additional high-risk groups include healthcare professionals or first responders who may have experienced significant moral injuries ([@bib98]; [@bib99]; [@bib236]) as a result of making unfathomable decisions on the job (e.g., providing admission or ventilator access to one patient at the sacrifice of another).

Yet, in addition to considering direct impacts of the novel COVID-19 virus on our population, it is imperative to understand the secondary potentially traumatic effects of the pandemic on individuals and communities. The combination of prolonged stress, close quarters, and self-isolation guidelines has increased risk of domestic violence, child abuse, and substance use ([@bib1]; [@bib149]; [@bib190]; [@bib209]). Indeed, physical and sexual violence may escalate without the regular societal checks provided by employers, schools, and loved ones. Furthermore, such violence may stem from and/or intensify more unbridled substance use ([@bib40]) emerging from a context where uncertainty and unpredictability are high, practical stressors (e.g., unemployment, financial stress, food insecurity) may be difficult to problem-solve, and social supports may be distant. Furthermore, in this pandemic, issues of grief and loss are inevitably interwoven with those of potential trauma. Spiritual and emotional grief processes to honor and emotionally mourn the losses of loved ones may be interrupted by this pandemic, potentially exacerbating or prolonging grief, traumatic bereavement, or PTSD reactions.

To understand the effects of COVID-19 on the mental health of those who experience it as potentially traumatic, we need to recognize first that the impacts of trauma may not be fully determined nor completely recognizable until after the traumatic stressor has concluded. The COVID-19 crisis is going to have a long, yet undetermined course, and thus our ongoing reactions to it are dynamic but indicative of *peri-traumatic* rather than post-traumatic coping ([@bib18]; [@bib113]). Based upon decades of research, we can expect the majority of the population, regardless of level of proximity to or interaction with COVID-19, to demonstrate resilience and to *recover* psychologically in the aftermath of the pandemic ([@bib5]; [@bib103]). A relative minority, the proportions of which are unknown, may emerge from the crisis with clinical or subclinical PTSD *or* with exacerbation in pre-existing PTSD symptoms and related mental health conditions (e.g., depression, substance use disorder). Women are at heightened risk of PTSD following potentially traumatic events ([@bib69]; [@bib179]) and racial/ethnic minority populations may be especially impacted due to socioeconomic inequities and health-related disparities with regard to financial security and access to healthcare and treatment ([@bib8]; [@bib50]; [@bib198]).

The intersections of trauma and the COVID-19 pandemic are complex. Many constellations of interweaving risk and protective factors, learning histories, and life circumstances can affect how trauma histories and potentially traumatic experiences during the COVID-19 crisis can affect individual journeys of recovery. For example, more unbalanced, negative individual interpretations of the COVID-19 crisis and related changes in beliefs about oneself, others, or the world may have lasting deleterious effects (e.g., "I am damaged"; "People cannot be trusted"; "The world is dangerous and unsafe"; [@bib17]; [@bib19]; [@bib104]; [@bib125]; [@bib194]). Similarly, avoidance of thoughts or emotions related to the COVID-19 crisis may increase the risk of developing PTSD symptoms and/or exacerbating or maintaining pre-existing trauma-related symptoms (e.g., [@bib162], pp. 409--436). Additional risk factors for the *development or exacerbation* of PTSD symptoms include a prior history of trauma or mental health disturbances, depressed or anxious mood, significant concurrent life stressors (e.g., financial problems, job loss, relationship stress), low social connectedness or support, sleep disturbance, substance use, and emotional numbing or detachment ([@bib46]; [@bib51]; [@bib73]; [@bib83]; [@bib196]; [@bib202]; [@bib221]). Navigating the COVID-19 crisis requires a tolerance of uncertainty that is challenging for all, but especially trauma survivors who may have endured, sometimes over months or years (e.g., combat, childhood abuse), unfathomable circumstances that were, by definition, unpredictable and uncontrollable (e.g., [@bib177]; [@bib222]). Undoubtedly, social connection and a sense of community and collectivism, hope, psychological awareness, and healthy coping will differentiate risk versus resilience trajectories during and after this crisis ([@bib19]; [@bib124], pp. 233--242; [@bib212]). Learning *who* suffers long-term negative effects of the COVID-19 pandemic, *why*, and *under what circumstances* will help us to understand *how* to intervene most effectively to psychologically support trauma survivors in the aftermath of this and future societal crises.

Indeed, reactions of trauma survivors to the COVID-19 crisis are also likely to be as diverse as the traumas and individuals themselves with the possibility of emergent themes. Theoretically, individuals with histories of being directly impacted by natural disasters, people recovering from severe medical conditions, and those with histories of imprisonment or captivity may feel especially emotionally reactive to the large community-level impact, the social distancing and quarantining aspects of weathering COVID-19, and the continual perceived health threat inherent to the pandemic. Individuals with interpersonal trauma histories may experience a solidification or exacerbation of maladaptive beliefs relevant to trust, safety, or power. Others may feel increased social detachment or engage in increased harmful, self-injurious, or suicidal behaviors, particularly those with mood or substance use disorders. For some trauma survivors, following social distancing and self-quarantine guidelines may lead to less frequent exposure to trauma-related reminders in the outside world and/or a lower perceived interpersonal threat due to social-isolation, but increased trauma-related avoidance during the COVID-19 crisis in turn may exacerbate PTSD symptoms in the long-term. A high-risk subset may emerge who are slow or reluctant to heed public health guidelines due to a reaction against efforts to control, an increased risk-taking propensity, all-or-none thinking, or helplessness resulting from a history punctuated by traumatic, uncontrollable events. This may lead to incessant attempts, by some, to attain perceived control via closely monitoring news, stockpiling food, or supplies, and maintaining constant vigilance. For those affected by trauma prior to and/or during the COVID-19 crisis, the current, chronically stressful global atmosphere where uncertainty reigns may feel especially overwhelming. For others, this crisis may foster growth and resilience as they endure and overcome a crisis of epic and unimaginable proportions.

2.3. Obsessive compulsive symptoms and disorders {#sec2.3}
------------------------------------------------

Obsessive-compulsive disorder (OCD) is a common (1--2% incidence; ([@bib150]; [@bib186]), disabling mental health condition characterized by presence of obsessions and/or compulsions ([@bib6]; [@bib127]). Symptoms present in a heterogeneous fashion across a number of dimensions, including contamination/cleaning, taboo obsessions (i.e., sexual, aggressive content), symmetry/repeating/ordering, and checking ([@bib134]). Childhood onset occurs in over 50% of cases and symptoms run a chronic course without adequate intervention ([@bib175]). Clinical presentation is further characterized by frequent comorbidity ([@bib203]) and variable degrees of insight ([@bib82]). The COVID-19 pandemic is likely to have a number of effects on those with OCD, as well as those at risk. This includes the potential for symptom exacerbation and increased incidence of OCD cases, as well as having implications for assessment and treatment post-COVID-19.

Patients with OCD commonly present with contamination obsessions and associated cleaning compulsions ([@bib128]; [@bib175]). Some individuals with contamination related OCD have reported that their symptoms have worsened in light of public health recommendations for increased cleaning behaviors (e.g., washing, wearing masks) and other safety behaviors (e.g., social distancing, wearing masks), which may be difficult for some patients to maintain within recommended guidelines. COVID-19 has become a feared outcome for many patients with contamination-related OCD similar to other what has been observed with other infectious diseases (e.g., HIV). Outside of contamination-focused symptomology, other obsessive-compulsive symptoms may be affected such as harm obsessions whereby someone fears that they may have unintentionally spread COVID-19. Stress has an established relationship with worsened obsessive-compulsive symptoms ([@bib2]; [@bib28]), and availability of coping strategies is taxed for many; this may further impact OCD symptom presentation as well as comorbidity patterns. Although systematic data have not been presented, clinical accounts support symptom worsening for some affected individuals while, on balance, many others have not experienced negative symptomatic change.

Beyond worsening of symptoms in those with OCD, there is the possibility that there will be increased cases in the near future. This may involve those with subclinical symptoms or other risk factors experiencing onset or worsening of symptoms. The behavioral cycle of OCD/anxiety highlights the role of negative reinforcement in which rituals/avoidance are reinforced by distress reduction and creating a cognitive sense of control (i.e., not getting COVID-19 is due to compulsions; [@bib180]). In this scenario, a person with or at risk for OCD may engage in rituals/safety behaviors in response to obsessional distress which in turn reduces anxiety and is perceived as reducing the risk. Reduction in distress may motivate further safety behaviors which, for some at risk, could begin to exceed recommended guidelines. While ordinary levels of risk have risen requiring increased hygiene, it remains to be seen what happens when risk levels decline. That is, do cleaning behaviors likewise decline or remain at elevated states thereby impacting diagnosis rates? Assessment approaches should continue to capture obsessive-compulsive symptoms that are impairing, distressing and excessive relative to current risk levels and not count symptoms that reflect behaviors consistent with accepted public health standards.

There are also treatment implications. The gold standard psychological treatment for adult and childhood OCD is cognitive behavioral therapy with exposure and response prevention (ERP; [@bib133]; [@bib158]). This treatment involves gradual exposure to triggers that evoke obsessive-compulsive symptoms while refraining from completing rituals or other avoidance behaviors. A core element to this treatment is that exposure to triggers involves exposure to 'ordinary' levels of risk. COVID-19 understandably has shaken what is perceived as ordinary; fortunately, adept therapists have shifted their practice to utilize exposures that reflect this new normal such as relying on imaginal exposures or exposures targeting rituals in excess of public health agency recommendations. At the same time, some clinicians have negative attitudes towards exposure ([@bib140]) which is related to reduced practice of this core therapeutic technique ([@bib64]). It will be critical to provide guidelines established by expert ERP clinicians for how providers integrate realistic COVID-19 concerns into their ongoing practice, as well as that in the future. A concerning possibility is that ERP treatment post-COVID-19 is diluted by virtue of therapists not practicing exposures to the actual level of risk.

3. Section two {#sec3}
==============

3.1. Tobacco {#sec3.1}
------------

Cigarette smoking remains the leading cause of preventable death and disability globally. Smoking may confer worse COVID-19 outcomes given extensive evidence for the negative impact of smoking on lung health and respiratory function ([@bib214]). Indeed, emerging evidence has identified smoking as a possible risk factor for adverse COVID-19 prognosis and disease progression ([@bib168]; [@bib218]). In the largest study of COVID-19 patients, 16.9% of severely affected patience were current smokers relative to 11.8% of non-severe patients ([@bib77]). An inverse pattern emerged with non-smokers such that a greater proportion of non-severe patients identified as a non-smoker relative to severe patients. Moreover, 25.5% of COVID-19 patients who either needed mechanical ventilation, were admitted to an intensive care unit, or died from complications related to the disease were current smokers relative to 11.8% of those not experiencing these outcomes. Similar disparities in COVID-19 severity across smoking status have been observed in other samples ([@bib122]; J. [@bib242]). Thus, these data, albeit preliminary and limited by sample size, indicate that smoking is a risk factor for COVID-19 progression ([@bib122]).

Taking a biological perspective to understand *why* smokers are more susceptible to severe COVID-19 symptoms, recent research has proposed that smoking and COVID-19 susceptibility and symptom severity may be related to an upregulation of the angiotensin-converting enzyme-2 (ACE2) receptor ([@bib27]). ACE2, a membrane-bound aminopeptidase that plays a vital role in cardiovascular and immune systems, is highly expressed in the heart and the lungs ([@bib215]; [@bib225]). Studies have established that ACE2 is a receptor for the COVID-19 virus (J. [@bib226]), and greater ACE2 gene expression has been observed in smokers compared to non-smokers ([@bib27]; [@bib37]; [@bib61]; [@bib213]; [@bib224]; [@bib237]; [@bib243]; [@bib244]). The upregulation in ACE2 creates an environment that allows greater potential for COVID-19 to infect human cells among smokers through more opportunity to bind to this receptor ([@bib159]; [@bib246]). In part, this biological mechanism may help explain observed sex differences in COVID-19. Specifically, COVID-19 symptom severity and mortality rates in China indicate worse outcomes for men than for women, where 52.1% of men and 2.7% of women are current smokers ([@bib167]; [@bib206]). It is possible that the elevated smoking rates among men in China, and therefore greater upregulation in ACE2, contributed to significant gender difference in COVID-19 incidence and severity (J. [@bib226]).

In addition to combustible cigarette smoking, there also is growing concern for the impact of electronic cigarette (e-cigarette) use on COVID-19 infection and disease progression ([@bib118]). Although it is believed that the worldwide distribution and adoption of e-cigarettes has the potential to increase population-level vulnerability to respiratory infecting diseases ([@bib159]), such as COVID-19, no studies have assessed e-cigarette use among COVID-19 patients ([@bib66]). Given evidence for the impact of various e-cigarette formulations on lung health and functioning ([@bib219]) as well as the fact that most e-cigarette users are former or current combustible cigarette users ([@bib143]), it is possible that product use will critically impact the course of COVID-19 among users. Additionally, similar to combustible cigarette use, it has been theorized that e-cigarette use may engage an upregulation in ACE2 that parallels that of combustible cigarette use and increases the likelihood of COVID-19 infection ([@bib27]). Further research on these products and their influence on COVID-19 outcomes is urgently needed.

A final point to consider is the effect that the COVID-19 pandemic itself has on smoking. One of the leading reasons for smoking is stress management ([@bib11]; Garey et al., in press[@bib71] ). The psychological effect of the current global environment, characterized by feelings of fear, uncertainty, isolation, and stress ([@bib139]), coupled with limited availability of adaptive coping tools due to regulations and consequences of COVID-19 (i.e., social distancing, financial hardship) likely increases the risk for smoking onset, increased intensity, and relapse ([@bib170]; [@bib204]). Smoking initiation and severity, in turn, increase susceptibility for COVID-19 and worse disease-related outcomes. Behavioral scientists must engage in targeted efforts to support current smokers and former smokers in achieving and maintaining cessation during this particularly challenging time. There are promising initial findings from smoking cessation programs implemented in smokers managing other infectious disease that may help guide some of these initiatives ([@bib154]). As more is learned about COVID-19, it is imperative that health care providers assess smoking (and e-cigarette) use status as well as relapse potential among former users and provide appropriate education and intervention to help mitigate the potential risk of this health behavior on disease infection and course.

3.2. Alcohol {#sec3.2}
------------

The (mis)use of alcohol is a leading risk factor for global disease burden and preventable death ([@bib54]; [@bib163]). Alarmingly, alcohol use, high-risk drinking, alcohol use disorder (AUD), and alcohol-related deaths were increasing before the COVID-19 pandemic ([@bib74]; [@bib228]). Despite the widespread belief that moderate alcohol consumption may confer health benefits ([@bib56]; [@bib184]), more recent work suggests that *any alcohol consumption* is associated with health risks ([@bib76]). In fact, given the immunosuppressing effects of alcohol both generally and in the respiratory system specifically ([@bib144]; [@bib207]), it is germane to consider the role that alcohol consumption, whether chronic or in acute response to the ongoing crisis, may have on contraction of the COVID-19 virus. In addition to the direct physiological impact of alcohol consumption on the body, the disinhibiting properties of alcohol ([@bib110]; [@bib164]) may put individuals at risk for other risky/poor decisions ([@bib72]). For example, those under the influence of alcohol may be more likely to violate social distance protocols, exhibit poor hand washing procedures, or refuse/forget to wear a face covering in public, leading to potential exposure to and/or spreading of the virus. Importantly, impulsivity has reciprocal relationships with alcohol such that consumption increases impulsive behaviors and individuals with greater trait impulsivity (mis)use alcohol to a greater extent ([@bib57]).

Moreover, the effects of impulsivity on alcohol (mis)use can be amplified by other factors, such as stress, to confer greater risk for alcohol (mis)use ([@bib67]). It is well-documented that stress, both acute and chronic, is a trigger for alcohol (mis)use ([@bib16]; [@bib22]). The COVID-19 pandemic has brought about both acute (e.g., work displacement, limited availability of cleaning supplies) and chronic stress (e.g., financial difficulty, isolation) that likely will contribute to alcohol (mis)use for coping. It also is reasonable to expect that alcohol (mis)use will worsen during the crisis in response to the stress and uncertainty. For example, during the 2008--2009 economic recession, although there was a decrease in prevalence of alcohol use overall (i.e., increase in abstainers), there was an increase in prevalence of binge drinking ([@bib26]). This suggests that there may be a realignment/concentration of problematic drinking such that a greater segment of those who do consume alcohol may be doing so in a maladaptive or harmful way.

Although sales to restaurants and events have reduced markedly during the pandemic, sales of online and to-go alcohol have skyrocketed ([@bib152]). Given shelter in place orders and limits on socializing, it is possible that greater amounts of alcohol are being consumed at home/solitarily relative to social contexts. Solitary drinking can, in some circumstances, lead to greater alcohol consumption than social drinking ([@bib109]) and is associated with greater alcohol-related consequences overall ([@bib44]). For many, the COVID-19 pandemic has led to significant social isolation with in-person socializing virtually eliminated and many working from home (if at all). These conditions may also exacerbate a common reason for alcohol-related relapse: boredom ([@bib117]). Without other adaptive ways to manage stress, socialize, or simply occupy one\'s mind, it is possible that craving for alcohol may intensify.

Finally, there are important treatment implications for alcohol (mis)use during COVID-19. Individuals already report numerous barriers to seeking drug/alcohol treatment ([@bib132]). In the wake of the pandemic additional barriers may arise such as the perception that one\'s treatment is not a priority during a 'life or death' pandemic or not worth the risk of leaving one\'s home. Alternatively, for those seeking treatment, there may simply not be local resources available or treatment facilities may have waitlists. Although the use of telehealth services are growing in general ([@bib58]), there is more work to be done, with specific considerations for low-income individuals (e.g. recently unemployed) who may be reluctant to spend money on treatment, perceive treatment to be a luxury, or not have technological resources or a private location to engage in telehealth. Affordable computer-based treatments without the need for a provider that focus on stress and alcohol use ([@bib171]) could be particularly pertinent during this pandemic.

3.3. Cannabis {#sec3.3}
-------------

Cannabis use rates continue to increase, with nearly 44 million individuals 12 years and older in the U.S. endorsing past year cannabis use in 2018, a rate greater than the rate in every year since 2002 ([@bib205]). Further, rates of cannabis use disorder (CUD) remain greater than rates of all other federally illicit substance use disorders combined. Despite the high rates of CUD, perceived risk of cannabis use continues to decline ([@bib157]; [@bib205]) presumably due at least in part to legalization of recreational and/or medical marijuana at the state level ([@bib100]). Notably, cannabis users report using more cannabis during times of heightened distress following national disasters such as the September 11, 2001 terrorist attacks, a pattern that was especially prominent among individuals who experienced post-traumatic stress disorder and depression ([@bib220]). It therefore follows that cannabis use and associated problems may increase during the COVID-19 pandemic.

Cannabis use increases during times of distress to manage negative affect. In support of this contention, cannabis users report relaxation and tension relief as one of the most common reasons for use ([@bib49]; [@bib87]; [@bib181]). Data from experimental studies support these self-reports. To illustrate, current cannabis users were randomly assigned to an anxiety-induction or non-anxious control condition and cannabis craving increased from before to during the task among participants in the anxiety condition, but not among those in the control condition ([@bib32]). These data indicate that cannabis users were especially vulnerable to wanting to use cannabis during an anxiety-provoking situation, which has direct implications for the COVID-19 pandemic characterized by heightened stress. Notably, this effect was specific to cannabis craving and was not observed for craving for alcohol or cigarettes in this sample of cannabis users. Coping motives are the most common reasons cited for wanting to use during laboratory-induced anxiety ([@bib35]). Prospective data collected via ecological momentary assessment also confirm that anxiety is positively, significantly related to cannabis craving at the momentary level, and is related to greater subsequent craving ([@bib31]). Further, although positive and negative affect were greater immediately prior to cannabis use compared to non-use episode, negative affect increased at a significant rate prior to cannabis use, and decreased at a significant rate following cannabis use; changes in positive affect were not significantly related to use ([@bib33]).

Further, the stress associated with the COVID-19 pandemic may serve as trigger for lapse and/or relapse among individuals undergoing a cannabis quit attempt. In a qualitative interview following cannabis quit attempts, situations involving negative affect and exposure to others smoking cannabis were among the most difficult situations individuals reported in which to abstain ([@bib90]). Among cannabis users undoing a self-guided quit attempt, data from ecological momentary analysis indicated that although positive and negative affect were significantly higher during cannabis lapse episodes compared to non-use episodes, when negative and positive affect were analyzed simultaneously, negative affect, but not positive affect, remained significantly related to lapse ([@bib34]). Again, the most common reason for use cited during lapse episodes was to cope with negative affect.

Not only could COVID-19 increase cannabis use, but cannabis use may exacerbate COVID-19 symptoms given that smoking cannabis damages the lungs. Respiratory toxins (including carcinogens) in cannabis smoke are similar to that of tobacco smoke but notably the smoking topography for cannabis leads to higher per-puff exposures to inhaled tar and gases ([@bib208]). Further, respiratory symptoms such as chronic cough, sputum, and airway mucosal inflammation are also similar between cannabis smokers and tobacco smokers. The impact on respiratory functioning of cannabis smoke has led for the consideration of cannabis use as a pre-exiting condition that could increase the likelihood of more severe complications should one contract COVID-19 ([@bib149]).

4. Section three {#sec4}
================

4.1. Sleep health and behavior {#sec4.1}
------------------------------

Sleep is a fundamentally restorative process, but it is also highly responsive to stress ([@bib93]). During times of increased stress, sleep, quite paradoxically, serves both as a major line of defense and as a source of heightened vulnerability. These relationships derive from the fact that sleep and immunological functioning are reciprocally related: sleep promotes healthy immune responses and healthy immune responses (e.g., to infectious agents) promote deeper, more restorative sleep ([@bib161]). Precise mechanisms are of course complex, but several specific links are noteworthy. Immune-signaling proteins called cytokines, such as tumor necrosis factor (TNF) and interleukin-1 (IL-1) directly target infection and inflammation but are also known to promote sleepiness and non-rapid eye movement (NREM) sleep ([@bib96]). The hormone melatonin, which provides an endogenous marker of circadian phase peaks during the nocturnal sleep period but also has important immunomodulatory effects. Conversely, the hypothalamus--pituitary--adrenal (HPA) axis and the sympathetic nervous system (SNS), two primary stress response systems, are down-regulated during sleep, decreasing immune-regulating cortisol levels ([@bib20]). However, when sleep is inadequate or disrupted, alteration in these systems is readily observable. Experimental sleep research provides overwhelming evidence for the detrimental effects of chronic sleep disruption on immune responses including increases in multiple inflammatory markers such as C-reactive protein, diminished immune response to vaccination, and enhanced susceptibility to bacteria and toxins ([@bib20]). Rather than representing enhanced immunity, elevated levels of inflammation are associated with a range of health risks including cardio-pulmonary disease ([@bib119]).

Sleep\'s inextricable role in human immunological functioning clearly place it at the forefront of critical behaviors during a pandemic. Unfortunately, multiple aspects of the COVID-19 pandemic threaten healthy sleep patterns which in turn endanger both physical and mental health. Widespread uncertainty, 24-h media coverage (including misinformation), fear for one\'s own health and the health of loved ones, and potential loss of employment/wages are but a few of the significant sources of stress present during these unprecedented times. Heighted psychological and physiological arousal elicited by such stress falls in direct odds with a calm, quiescent state necessary for sleep onset and maintenance. Further, common behaviors aimed at managing increased stress and anxiety such as smoking, alcohol consumption, and decreased physical activity can give rise to or worsen sleep disruption via known negative effects on sleep duration and quality ([@bib91]). Moreover, sleep deprivation can amplify inflammatory responses ([@bib25]), increasing the risk for poor outcomes in COVID-19 as unrestrained inflammation is implicated in the pathophysiology of the disease ([@bib70]).

Although predisposing (e.g., genetics) and precipitating (e.g., trauma) factors play a role, stress is considered a primary cause of insomnia ([@bib146]) and among insomniacs, perceived inability to sleep often becomes a major source of stress in its own right. Studies that have systematically examined incidence and severity of insomnia symptoms during a global pandemic are unavailable despite ubiquitous anecdotal reports and cautions from health professional regarding the immunosuppressive effects of poor sleep. However, in a recently-published study conducted between January 29 and February 3, 2020, C. [@bib241] surveyed medical staff responding to the COVID-19 pandemic in China using the Insomnia Severity Index (ISI; [@bib145]). More than a third of workers (36.1%) endorsed symptoms indicative of clinical insomnia and those with insomnia reported elevated levels of depression. Insomnia is well-known to herald the onset of depression both acutely and years later even among those who have never been depressed ([@bib10]). Studies directed at uncovering precise mechanisms of affective risk during the COVID-19 pandemic must therefore consider the presence and severity of insomnia symptoms.

The COVID-19 pandemic also has upended daily routines and associated 'cues' that serve to maintain regular sleep schedules. Working from home, altered mealtimes, increased sedentary behavior, social distancing, and increased "screen time" are only some of the changes that hold potential to disrupt circadian rhythms that govern sleep-wake patterns. Other factors such as social activities also can affect sleep-wake patterns. The human internal circadian clock runs slightly longer than 24 h and therefore needs to be 'entrained' to the 24-h day via internal and external cues ([@bib52]). Sunlight is the most potent exogenous cue that aligns our internal rhythm to the external environment, but quarantine measures and greater time spent indoors means that many individuals are receiving inadequate dosages of light exposure. Although public health guidelines center on sufficient sleep duration ([@bib227]), sleep timing is equally critical for overall health and well-being. Misalignment of the sleep period with the body\'s 'biological night' is routinely linked with a host of serious risks, including anxiety, depression, suicide, cardiac events, and several forms of cancer ([@bib15]). Healthcare workers who are working long hours and night shifts during the COVID-19 pandemic are therefore a particularly high-risk group for circadian shifts and associated comorbidities. Considering sleep\'s role in immunological function, this represents an area of priority for future research.

4.2. Chronic illness: using HIV/AIDS as an exemplar {#sec4.2}
---------------------------------------------------

The intersection of COVID-19 with pre-existing chronic medical illness (e.g., cardiovascular disease, diabetes, HIV) raises additional challenges to the patient for managing multiple treatment cascades. These challenges are exacerbated by the poorer survival and disease course for patients with underlying medical conditions ([@bib61]) which in turn seems to be driving, in part, the alarming COVID-19 racial disparity ([@bib114]). The overlapping epidemic of COVID-19 with HIV, for example, presents unique challenges for HIV access to care, HIV treatment engagement, and prevention.

At this time, it is not known whether HIV infection increases susceptibility to COVID-19 infection or if it exacerbates the likelihood of poor COVID-19 outcomes. However, people living with HIV may have other comorbidities, such as cardiovascular disease and chronic lung disease, that increase the risk for a more severe course of COVID-19 illness ([@bib78]; [@bib79]). There is also a concern that individuals who are immunocompromised, such as those with HIV, may be at greater risk for severe COVID-19 symptoms ([@bib41]; [@bib59]).

In the U.S., most people living with HIV (PLWH) are tested, linked to HIV care, well engaged in antiretroviral treatment, and achieve HIV viral suppression thus ensuring their optimal health and protecting the public health by containing onward transmission ([@bib42]). However, structural and individual barriers to treatment and prevention create enduring inequalities and significantly increase the risk of infection, reduce access to, and engagement in, HIV care, and compromise participation in HIV biobehavioral prevention among particular risk groups. Gay and bisexual men (particularly Hispanic and African American men) are most impacted by HIV and account for nearly 70% of new HIV cases. HIV incidence rates in the U.S. are also significantly higher for those who are homeless or living in poverty ([@bib55]).

With respect to individual barriers to care, PLWH are disproportionally affected by traumatic life experiences, anxiety, depression, and substance use ([@bib29]; [@bib148]; C. [@bib155]). Each of these also have been associated with poorer engagement in HIV care, worse antiretroviral medication adherence, and poorer HIV disease course. Their co-occurrence and interaction significantly increases both the risk for HIV infection ([@bib141]) and poorer HIV disease management among those already infected ([@bib85]; [@bib166]). These mental health barriers to full engagement in HIV care may well be exacerbated by increased levels of COVID-19 specific anxieties and increases in general health-related anxieties. The requirements of social distancing also may contribute to feelings of isolation and loneliness which may in turn contribute to increased depression or depression-related withdrawal. Both anxiety-related avoidance and depressive related withdrawal will likely have negative consequences for self-care generally and for HIV care specifically. These increases in distress will occur at a time when access to behavioral health services is already severely restricted. Some PLWH who become co-infected with COVID-19 will already be struggling with HIV disease management (e.g., missed medical appointments, sub-optimal medication adherence) and may require additional supports to manage COVID-19 care and treatment at a time when many routine supports may not be available due social distancing and lack of routine medical services.

Protecting access to care and treatment among those already struggling with the complexities of the HIV care cascade who must now manage the additional burdens of the COVID-19 illness is a robust clinical concern. Here, we underline the importance of community ([@bib39]) and health worker based approaches ([@bib160]) to HIV treatment and protecting access to care through innovative and virtual care models. Many of those at risk for being lost to care during this COVID-19 pandemic also may be vulnerable to perceived stigma ([@bib107]; [@bib123]). Many will have multiple stigmatized identities with respect to HIV status, COVID-19 status, substance use, sexual or gender minority status, and others. Keeping our community members and peers involved in our service delivery will help ensure our treatments are delivered in stigma-free contexts. Empirical support for integrated treatment platforms that address mental health ([@bib92]; [@bib188]) and substance use issues ([@bib142]; [@bib187]) to protect engagement in HIV treatment and prevention ([@bib130]; Conall [@bib156]) are available to guide these initiatives. In addition, protecting access and supporting engagement (virtual or otherwise), to mental health and substance use treatment will be critically important. These approaches may be particularly key for protecting access to HIV prevention services (i.e., HIV testing, access to Preexposure Prophylaxis \[PrEP\]) for those at risk for HIV. Access to these services may be particularly important for those whose behavioral risk profiles and risk appraisals may be disturbed because of the impact of social distancing on usual patterns of substance use or sexual behavior.

4.3. Physical activity {#sec4.3}
----------------------

Although much remains unknown about COVID-19 and the mental health consequences of the pandemic, it is likely that regular physical activity offers protective effects. Regular physical activity reduces risk of and helps manage conditions that appear to increase risk of adverse outcomes of COVID-19 (e.g., obesity, cardiovascular disease, diabetes; [@bib115]), and improves immune function ([@bib153]) which likely positively affects the progression of COVID-19. It also buffers the effect of stressors and (in part thereby) can prevent the onset of mental health conditions ([@bib86]; [@bib94]). Further, diminished physical activity can disrupt sleep quality ([@bib36]; [@bib240]), which increases susceptibility to infection and mental and physical illness (see Sleep section). Hence, establishing or maintaining a regular physical activity habit has the potential to mitigate the impact of the pandemic both at a personal and societal level.

Establishing and maintaining a regular physical activity habit has proven to be challenging. Indeed, only 24% of adults meet the guidelines set forth by the Department of Health and Human Services ([@bib229]). The COVID-19 pandemic has impacted several factors, including a change in the daily routine and increased stress and anxiety, that can affect the intent of or ability to engage in behavior change. It is important to acknowledge the relationship between factors such as stress or changes in routine and physical activity participation can vary in strength or direction (i.e., negative or positive) depending on the individual and their context. For example, for some routine changes have created barriers for exercise participation, while for others changes to the daily structure have opened opportunities to engage in regular exercise. Similarly, stress and anxiety at the "right" level can be motivating for some make exercise part of their daily routine, but when stress and anxiety become overwhelming, automated emotion action tendencies often cause people to move away from healthy (coping) behaviors such as exercise ([@bib165]). Importantly, such relationships may further vary within and across individuals depending on other individual difference variables (e.g., risk factors, protective factors, \[mental\] health diagnosis) and contextual factors (e.g., job loss, financial stress, isolation).

Research aimed at understanding the relationship between COVID-19 and physical activity mostly likely will benefit from considering the importance of individual differences and the influence of contextual factors. Comprehensive assessment batteries and statistical models that include the testing of these complex moderation effects are key. This perspective that acknowledges nuance in the relationship between COVID-19 (pandemic) and physical activity also will aid efforts to develop or fine-tune intervention programs for physical activity uptake.

5. Section four {#sec5}
===============

The COVID-19 pandemic, although still ongoing and presently under investigated from a behavioral health perspective, is apt to impart acute and potentially chronic exacerbations in psychological symptoms and disorders, addictive behavior, and health behavior and chronic illness. Across various phenotypes overviewed in the current essay, previous scientific work and theoretical models predict COVID-19, regardless of acquisition of the virus, has and will continue to have a strong negative psychological impact on negative mood states, various forms of substance use, and sleep, chronic illness, and physical activity. Although many of these relations would be expected, theoretically, to be negative, select subgroups will certainly adaptively respond to COVID-19 related stress (e.g., improve their physical fitness, improve self-care routines, quit/reduce maladaptive behaviors that place them at risk). In this final section of the paper, we discuss sociocultural considerations, developmental issues, and the role of individual difference factors for COVID-19-related psychological, addictive, health behavior and chronic illness. We conclude by offering an integrative COVID-19 model that could be used to guide research focused on the stress-related burden of the pandemic.

5.1. Sociocultural factors {#sec5.1}
--------------------------

Certain subpopulations and contextual factors (e.g., loss of work) are likely to signify a vulnerability gradient for COVID-19 in terms of mental health, addictive behavior, and health behavior. Although there are numerous possible sociocultural factors that could be relevant, we highlight first responders and medical professionals, economic adversity, and racial/ethnic factors as three prototypical factors of public health importance.

**[First responders and healthcare professionals.]{.ul}** Of all the sectors of the population, first responders and front-line healthcare professionals are arguably at the greatest risk for at least acute disruptions in anxiety, stress, and negative mood. First responders and healthcare professionals at the front line of the COVID-19 pandemic have at their core mission to protect and preserve life ([@bib176]). These groups, although engaging in a diverse range of specific occupational activities (e.g., direct medical care, transport, public safety enforcement), share in common that they are among the first to respond to the COVID-19 crisis and take primary responsibility for attending to COVID-19 related health issues.

First responders and healthcare professionals are undoubtedly experiencing emotionally challenging and unpredictable situations that can place their lives in danger. The acute emotional effects of managing COVID-19 cases is likely to be amplified by heavy work schedules and reduced access to and isolation from social support systems (e.g., self-isolation after finishing a shift). It is likely that first responders and healthcare professionals working with COVID-19 cases in hospitals will be exposed to potentially traumatic events, the greater-than-usual experience of life-threatening situations, working with emotional strain related to isolation of patients from their families (e.g., compassion stress in the form of offering emotional support to patients in a manner that family or caregiver of patients would typically offer), and exposure to the struggle to life and death. These experiences are apt to challenge the coping resources of even the most seasoned professionals, which can result in higher degrees of anxiety, stress, and depressed mood ([@bib111]). Such elevated stress levels are likely to be related to changes in cognition and physical health, including emotional exhaustion, fatigue, sleep dysfunction, and problems with interpersonal relationships ([@bib108]; [@bib112]). Cognitive-based beliefs about personal safety and health can be altered and memories of potentially traumatic events engrained ([@bib195]).

Collectively, the COVID-19 related stress burden, as discussed in several sections of the current essay, will have a high likelihood of being related to increased risk of anxiety and depression for first responders and medical professionals working at the front line. Moreover, consistent with past literature of these populations, the regulation of affect will be associated with addictive and health behavior to modulate such affect (e.g., physical activity, substance use). Although some regulatory behavior will be adaptive (e.g., increasing sleep where possible to aid in recovery, engaging in regular physical exercise), others may be less adaptive (e.g., smoking to reduce stress) and promote the risk for other health problems (e.g., physical illness).

**[Economic adversity.]{.ul}** Economic hardship related to COVID-19 is already evident at numerous levels of analysis, including job loss, reduced earnings, higher debt relative to assets ratio, inability to pay mortgage and bills, meeting governmental guidelines for poverty status, and worry about financials resources going forward due to the turbulent nature of the economy. Past work has shown that economic hardship is related to behavioral health problems, including psychological disorders, addictive behavior, physical health problems, and interpersonal dysfunction in adults and children (K. J. [@bib47]; [@bib191]). For instance, economic adversity has been linked to reduced social competence and elevated physiological markers of stress (K. E. [@bib23]; [@bib63]). Further, economic hardship is related to self-regulation capacity and the corresponding difficulty in dealing with additional responsibilities. For example, past work has found limited socioeconomic resources are related to harsher parenting behavior and greater substance use (R. D. [@bib48]). The negative effects may be particularly profound when economic hardship is severe or chronic ([@bib53]; [@bib126]). The totality of worsening economic conditions for individuals and families in the larger context of an uncertain economic future are apt to be related to elevations in anxiety, stress, and depression as well as other negative emotional states (e.g., anger, frustration, fatigue; [@bib151]). Such emotional symptoms and problems are likely to be related to elevations in substance use and other maladaptive behavior (e.g., less supportive interpersonal behavior, less affection) and may exacerbate chronic health conditions. Other work has found that these processes also disrupt social interconnections ([@bib193]).

Primary care givers who have children home from school, are unlikely to be able to work at their full capacity even with added flexibility in schedules. Although certain occupations have decreased activity, many have not. Therefore, it could be expected that for individuals with added responsibilities of educating their children at home occupational stress may be greater compared to those without such responsibilities. Further, it is possible that the accumulation of occupational responsibilities that are not addressed for persons with additional educational responsibilities will accumulate and make it more challenging to recover when going back to 'normal,' resulting in a greater degree of occupational stress.

Grappling with lower socioeconomic states related to COVID-19 will, for certain segments of the population, offer an additional psychological challenge. Indeed, past work has repeatedly documented that lower socioeconomic status is related to adverse health outcomes for chronic illness and mortality rates ([@bib3]; [@bib4]). Moreover, harms faced by people who cannot afford not to work in dangerous settings can exacerbate the psychological and health risk associated with COID-19. Further essential workers are more apt to be persons of color ([@bib84]). Certain groups will be more likely to recover than others, which past work indicates is related to poorer health outcomes even at higher socioeconomic levels ([@bib105]). Moreover, research has found that lower socioeconomic persons experience more chronic stress and negative life events ([@bib201]). Additionally, lower socioeconomic status is related to cognitive biases for threat ([@bib43]), which engender greater degrees of interpersonal conflict and heightened negative emotional states ([@bib129]; [@bib200]). It would be expected that such negative emotional experiences will be related to maintained direct relations with poorer health behavior and health outcomes ([@bib131]). In fact, research has consistently found that lower socioeconomic status is related to greater degrees of anxiety, stress, and depression when compared to those higher in socioeconomic status ([@bib135]). This heightened stress reactivity may be at least in part attributable to having fewer resources. Consequently, those struggling with a lower socioeconomic status due to COVD-19 may be more contexts in which they must utilize their emotional resources and be less likely to be in a sociocultural context wherein such resources can be replenished ([@bib88]). This perspective is in line with past work that has found that when persons are exposed to chronic stress, emotional resources are challenged, and there is a greater risk for future emotional distress (N. [@bib24]; [@bib62]).

**[Racial/ethnic considerations.]{.ul}** There is broad band evidence that significant health disparities exist for persons of racial/ethnic minority in the U.S. and beyond prior to COVID-19 for psychological, addictive behavior, and health behavior as well as chronic illness. For example, African American/Black individuals experience a disproportionate burden in disease morbidity, mortality, disability, and injury ([@bib137]; [@bib138]). Indeed, African American/Black individuals remain significantly and consistently more at risk for early death than do similar non-Latinx White individuals ([@bib234]; [@bib235]); overall early death rates of African American/Black individuals are comparable to those observed among non-Latinx Whites in the U.S. decades ago ([@bib116]; [@bib233]). Differences in prevalence and rate of growth of chronic illness are not accounted for solely by exposure to lower income environments ([@bib68]). Indeed, social determinants of health (e.g., racism; [@bib106]), addictive behavior (e.g., tobacco use; [@bib189]), and stress represent robust and consistent factors related to health inequalities among African American/Black individuals and those from other underrepresented racial/ethnic groups. The COVID-19 pandemic has appeared to strike racial and ethnic minority populations (e.g., African American/Black) hard and with possible longer-term consequences. For example, less access to health care services for chronic illness, addictive behavior, and mental illness could exacerbate COVID-19 related symptoms or promote a greater degree of stress-related burden associated with the pandemic (e.g., worry that loved ones, if infected, cannot access care). Consequently, addictive behaviors (e.g., smoking, alcohol misuse) and health behaviors (e.g., disrupted sleep, emotional eating) may be used in the short-term to cope with such COVID-19 related stress, increasing the longer-term risk for more severe negative emotional symptoms and health complaints (e.g., pain) and chronic health problems (e.g., obesity).

Additionally, situations characterized by mass fear and confusion, such as the current pandemic, also can elicit a human instinct to resolve the confusion and mitigate the fear by identifying a culprit for the introduction or spread of the disease ([@bib13]; [@bib30]). Asian American persons are one group that has been singled out as responsible for the COVID-19. The misdirection of fear and/or anger related to COVID-19 toward a racial or ethnic group instead of the disease, however, can perpetuate fear and contribute to racism and stigma. Several reports have already documented the rise in violent crimes and discrimination experienced by Asian American persons related to COVID-19 beliefs (E. [@bib120]). COVID-19 specific language, such as referring to COVID-19 as 'the Chinese virus,' has created a platform to propagate stigma and discrimination towards Asian Americans. It is likely that stigma and discrimination experienced by Asian Americans in response to COVID-19 will increase emotional distress, coping-oriented addictive behavior, and may alter health behavior or exacerbate chronic illness.

It would also be remiss to not call explicit attention to the fact that societies marked by greater economic and social inequality experience far more medical, psychological, and social pathology than do societies where such wealth inequalities are less pronounced ([@bib230], [@bib231]). Further, such adverse effects occur across social classes, not merely among the most disadvantaged. Yet, the adverse effects of economic (and thus social) inequality hurt everyone, although the poorest or most marginalized are affected the most ([@bib173]; [@bib232]).

5.2. Developmental considerations {#sec5.2}
---------------------------------

There are far-reaching implications for psychological health, addictive behavior, and health behavior from a developmental perspective. For children, despite COVID-19 appearing to have less severe symptoms and lower mortality rates than other age groups, are among the highest risk groups ([@bib199]; [@bib245]). Estimates suggests that there are over 1 billion children not in school ([@bib45]). The economic impact of COVID-19 will likely be related to greater risk for children to be utilized to offset such financial hardship (e.g., selling merchandise on the street, forced begging for food and goods) and be a more likely to be abused ([@bib38]). For example, it is possible that children will be more likely to be used for child labor and be exploited for sexual behavioral and experience corresponding risk for sexual disease and pregnancy as well as serious psychological distress. Interpersonal violence and child abuse will affect children at a significant rate, especially under conditions wherein there is no oversight from educational systems due to quarantine. World health organizations are already predicting an increase in children who will be orphaned and exposed to abuse and neglect ([@bib45]). Child abuse is less likely to be detected during the COVID-19 pandemic because the reduction or lack of child protection agencies monitoring cases, and teachers less able to detect signs of abuse. Further, children who received meals at school through government programs such as the National School Lunch Program may now no longer have access to nutritious food, which can negatively impact their development.

The lack of structure from schooling and missed education will have a lasting impact on well-being and apt to be related to increased anxiety, depression, and stress about educational attainment and progress going forward ([@bib217]). Although on-line school may help offset some of these challenges, disparities will exist for those who are most vulnerable, including those who lack internet access or cannot afford technology. Older children and young adults may be more likely to drop out of school to help offset family needs. Children and youth also may be engaging in more on-line behavior in general or due to emotional distress (e.g., loneliness due to social isolation) and be increasing the chance for solicitation from others who prey on their emotional vulnerabilities ([@bib172], p. 528). Lacking access to physical activity due to quarantine protocols may reduce fitness levels and immunological response as well as decrease psychological wellbeing ([@bib185]).

Children and youth in juvenile systems, such as orphanages, already were exposed to high density living conditions and often lack access to proper medical or psychological care. The COVID-19 pandemic is likely to place pressure on such systems (e.g., more children) and the physical environments of these settings may be amenable to the spread of infection. Likewise, refugee or otherwise displaced children and youth often live-in high-density environments wherein social distancing is challenging if not impossible. Further, lack of access in these settings to cleaning supplies and water can catalyze the spread of COVID-19 or even the basic fear of acquiring the virus. To the extent the COVID-19 challenges the medical system, it is possible other forms of medical care necessary for child welfare (e.g., routine exams, immunizations) will be reduced, as was the case during other pandemics such as Ebola ([@bib147]). Collectively, COVID-19 places an enormous stress on children and youth, placing them at an increased risk for psychological disturbances and physical health vulnerability ([@bib121]).

COVID-19 also will affect ranges of the lifespan, including adults and older adults. The well-publicized health risks for older adults place an obvious psychological and health pressure on this group. Older adults are among the most likely to have a chronic illness (e.g., diabetes, cancer, cardiovascular disease) and consequently they maintain an increased vulnerability to deteriorating health and death from COVID-19. However, even in the absence of exposure to the virus, the fear and worry about contracting the disease is apt to be significant for this group, especially when in homecare facilities such as nursing homes or hospitals ([@bib7]). This group also is at significant risk for lacking transportation for food, which could challenge the quality of nutrition and have a negative effect in immunological function. Similarly, older adults are among the least physical active groups, which again, will have the potential for decreasing psychological wellbeing and immunity.

Although not specific to older adults, the potential for disruption in grief and loss of others also is a significant psychological stressor. During the pandemic, regular methods of grieving such as funerals have been limited if not all together impossible. The inability to grieve with others or as traditionally done may spur escalation in psychological distress (e.g., sadness, depression) and complicate the grief process ([@bib223]). To the extent that grief is impaired, individuals may engage in maladaptive addictive behaviors (e.g., alcohol misuse) to cope with the aversive experiences. Similar types of emotional reactions may occur when parents are separated from their children due to quarantine protocols and disruptions in travel (e.g., cannot travel to see children located in another region).

5.3. Individual differences relevant to psychological dysfunction, addiction, and health behavior {#sec5.3}
-------------------------------------------------------------------------------------------------

There are several individual difference factors at a psychological level of analysis that will place people at an increased or decreased risk for psychological problems, addiction, and poor health behavior, and chronic illness during and after the pandemic. Research over the past few decades has theorized and found consistent empirical support for emotional symptoms and disorders as well as addictive behavior being explained by individual differences in transdiagnostic processes ([@bib192]). Transdiagnostic factors may contribute to onset, maintenance, and exacerbation of emotional symptomatology and addictive and health behavior. A core aspect of transdiagnostic models is that they seek to identify basic processes underlying multiple, usually comorbid, psychopathologies or addictive behavior.

One set of transdiagnostic factors relevant to COVID-19 may be those that are "reactive" vulnerabilities; that is, individual differences that reflect a heightened emotional response to stressful stimuli. Such vulnerabilities influence emotion experience by enhancing or diminishing the normative response to emotion stimuli and states, resulting in an excess or deficit, respectively, beyond typical emotional functioning; or altering the type of response to emotion stimuli and states ([@bib75]; [@bib182]; [@bib247]). In both instances, such reactive processes may be maladaptive because they serve to reinforce the intensity and frequency of future emotional symptoms. For example, when faced with negative emotion states, individuals with an emotional vulnerability factor that limits their capacity to handle distress may be more apt to execute behaviors that preclude habituation to negative emotion states, which could ultimately increase the intensity of future negative affect and solidify beliefs and learned responses that interfere capacity to adaptively respond to distress.

To illustrate, a transdiagnostic factor that may be especially relevant to COVID-19 related stress responsivity, substance use, and physical health is anxiety sensitivity ([@bib210]). Anxiety sensitivity is a malleable, cognitive-affective factor reflecting the tendency to respond to interoceptive distress with anxiety ([@bib136]). Anxiety sensitivity is related to, yet distinct from, negative affectivity and trait anxiety ([@bib102]). Anxiety sensitivity has demonstrated racial/ethnic, gender, age, and time invariance ([@bib60]; [@bib65]; [@bib95]). Given COVID-19 can produce physical sensations and even when not infected, COVID-related stress can elicit a range of interoceptive sensations, persons higher in anxiety sensitivity may be more be emotional reactive to such stimuli and engage in behavior to dampen stress symptoms (e.g., using tobacco, alcohol). For example, persons may interpret the onset of aversive bodily sensations (e.g., runny nose, cough, fever) as intolerable or catastrophic, exacerbating the experience of such interoceptive symptoms. Further, interoceptive symptoms might be particularly salient to persons with higher anxiety sensitivity who are prone to health inequalities (e.g., racial/ethnic minorities, persons in financial stress), as they may be more apt to perceive these internal sensations as uncontrollable because resources to regulate symptoms (i.e., adaptive cognitive and behavioral skills) are likely diminished due to chronic stress exposure (e.g., low socioeconomic status, discrimination). In turn, persons higher in anxiety sensitivity may be motivated to use substances to reduce emotional and interoceptive distress, elevating their chance for physical illness and compromised immune system function. Although this illustrative example represents only one of many possible transdiagnostic amplifying factors, it draws attention to the fact that individual differences in psychological processes are apt to play a central role in the relation between COVID-19 related stress and mental health, addictive behavior, health behavior, and chronic illness.

Individual difference factors also may play roles in offering resilience to COVID-19 related stress. That is, individual differences may contribute to the likelihood of a resilient response to COVID-19 in the short and long term. Thus, in addition to the many situational and contextual factors, individual difference factors will likely shape the level of resiliency to COVID-19 pandemic. Here, it is likely individual difference factors that de-amplify stress responses will play a central role in offsetting relative risk for psychological, addictive, and health behaviors problems and exacerbation of chronic illness ([@bib174]). As with affect amplifying factors, such as anxiety sensitivity, there most certainly is a range of factors of potential importance, including flexible coping repertoires, mindfulness, self-efficacy, self-compassion, and proneness to experience positive affect. To illustrate, individual difference in the capacity to accept difficult COVID-19 related stress may offset the potential escalation of anxiety, stress, and depression and mitigate the need for addictive or unhealthy behaviors (e.g., emotional eating) to delimit aversive internal experiences ([@bib178]). Consequently, the corresponding risk for health complaints or worsening of chronic health conditions can be offset. Indeed, there is a large theoretical and empirical literature that suggests the capacity to accept difficult emotions experiences is related to psychological well-being and adaptation. For example, one of the reasons meditative practice is related to decreased stress is via change emotional acceptance ([@bib211]). This type of work has robust implications in efforts to intervene on COVID-19 related stress in the immediate context and for those that struggle to regain stability and growth in the future in terms of mental health, addictive behavior, and health behavior.

### 5.3.1. Theoretical model of COVID-19 stress burden {#sec5.3.1}

Despite the present lack of systematic empirical work on COVID-19 in terms of behavioral health problems, there is good theoretical basis from past scientific work to hypothesize that COVID-19 related stress burden, due to a myriad of sources, may play a major vulnerability role in terms of mental health, addictive disorders, and health behaviors as well as chronic illness. For some, the stress-related burden of COVID-19 may elicit fundamental changes in risk potential and serve as a fertile basis for future behavioral health problems. For others, the ability to adapt to COVD-19 will offer a different course; one that is characterized by greater stability, speed of recovery, and growth. Further, it is important to recognize that the adaptation process to COVID-19 related stress is apt to be non-linear in many instances. That is, contextual factors (e.g., future life stressors, access to social support) can influence the degree of risk for future problems.

Research described in this essay provides a basis to develop a theoretical model that could be used to evaluate COVID-19 related stress burden on psychological, addictive, and health behaviour problems. We therefore begin this section by briefly outlining a general model that can be used as a heuristic for understanding the complex issues at hand. See [Fig. 1](#fig1){ref-type="fig"} for a graphical depiction of the model. In general, we predict individual differences in affect amplifying and de-amplifying factors will predict the course of psychological, addictive behavior and health behavior and chronic illness even when considering differences in exposure to COVID-19 experiences (e.g., time of quarantine, acquisition of virus). We would predict, based on past work that transdiagnostic affect amplifying factors will influence addictive and health behaviour, which in turn, will increase (or decrease if de-amplifying) the risk of chronic illness and psychological problems and their comorbidity. Further, we can expect that this type of perspective will be moderated by daily stress in the future and access to stress-dampening resources (e.g., social support). Accordingly, certain subgroups more prone to greater and more chronic stress, such as first responders and racial/ethnic minorities and orphaned children, may be particularly vulnerable. This conceptual model predicts that the associations which exist between are reciprocal and dynamic.Fig. 1Theoretical Model for how COVID-19 stress burden may be associated with addictive problems and health behaviors, and how these may be associated with later chronic illness and psychological problems.Fig. 1

Although the model offered here is purposively general and is offered only as a heuristic, it is presumed that there is, in fact, specificity between specific affect amplifying and de-amplifying factors, moderators, mediators, and various forms of psychological and chronic illness. That is, a specific type of individual difference factor like anxiety sensitivity is linked to a particular type of problem (e.g., anxiety disorder, worsening of a chronic respiratory illness, severity of hazardous drinking) via a specified mediating process (e.g., smoking, sleep disruption) in the context of certain moderating variables (e.g., higher levels of COVID-19 stress burden). The core idea being that the underlying mechanism in this hypothetical example may be quite different from that explaining other problems.

The above theoretical model requires empirical testing, and if it is confirmed, one next logical step would be to intervene in it to reduce the burden of mental health, addictive disorders, poor health behaviours, and chronic health conditions related to COVID-19 stress burden. Ideally, this type of intervention approach would target the root of the pathway, including affect amplifying (i.e., decreasing levels) and de-amplifying (i.e., promoting growth). However, intervention efforts sit in the fact that the healthcare system will continue to shift and adapt to treatment delivery, including the uptake of digital health technologies. Digital health, including mobile health (mHealth), telemedicine/telehealth, and health information technology (e.g., mobile phones, wearable sensors), can be used to develop scalable interventions to promote adherence public health guidelines for mitigating the spread of COVID-19. They also can be combined with greater attention to affect amplifying (i.e., decreasing levels) and de-amplifying (i.e., promoting growth) factors that govern many psychological, addictive, and health behaviour processes. Here, there is great opportunity for growth of digital health interventions to offer standalone clinical grade therapeutic tactics and as an adjunct to face-to-face interventions. This type of work can close the gap in access to care and offer evidence-based interventions to large segment of society. For example, digital interventions can be used to combat resistance to public health measures at the level of individuals and institutions with a consideration of individual difference factors that affect emotional and behavioral self-regulation. Indeed, the public\'s response to public health measures is itself a potential risk and protective factor for many of the psychological, addictive, and health behavior problems reviewed in this essay.

6. Conclusion {#sec6}
=============

The public health impact of COVID-19 on psychological symptoms and disorders, addiction, and health behavior is substantial and ongoing. There is a need for financial and social investment in research to better understand how COVID-19 affects the onset, maintenance, and relapse potential for some of the most common, costly, and chronic behavioral health conditions in the general population. Further, there is a need for the study of the role of psychological processes, addictive behavior, and health behavior in terms of the onset and maintenance of COVID-19 infection and stress burden. There most certainly will be a demand for preventative and intervention efforts for managing the impact of COVID-19 among individuals with elevated negative mood symptoms and disorders, addictive behavior, and certain health behaviors (e.g., sleep disorders) and chronic illness. This work is important to offset the current and projected burden to personal, system, and societal entities, and for providing a theoretical and empirical knowledge base for future pandemics. We presented a heuristic model, which posits that COVID-19 related stress and mood, addictive, and health behavior may, in fact, exacerbate each other via several distinct mechanisms. Future research in this emerging area has the potential to refine both theory and application with respect to COVID-19 and its relation to affect, addiction, and health behavior as well as chronic disease.
